Research
Energy balance
GLP-1 agonists reduce food intake and delay gastric emptying, contributing to weight loss.
Understanding these mechanisms can help practitioners better utilize GLP-1 agonists in treatment.
StrongSupportsmedium confidence
Liraglutide and semaglutide have great weight loss effect through reducing food intake and delaying gastric emptying.
Why this rating
Based on the review of pharmacotherapy strategies.
Source
Why does <scp>GLP</scp> ‐1 agonist combined with <scp>GIP</scp> and/or <scp>GCG</scp> agonist have greater weight loss effect than <scp>GLP</scp> ‐1 agonist alone in obese adults without type 2 diabetes?
Yuchen Jiang et al. · Diabetes Obesity and Metabolism · 2024
DOI 10.1111/dom.16106
reviewCited 18×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →